Search

Prevention science over the past years has accumulated evidence on the effectiveness of drug prevention interventions (Sloboda et al. 2014). In Europe this improvement has been a consequence of priorities defined by EU drug strategies since...

Presented at Thessaloniki 2024, on the 27th of June, 2024.

Moderator: Mr. Mariano Montenegro (⚑ Chile) - Colombo Plan Chile Office

Presentations: 

Mariano Montenegro - Introduction to Treatment Quality Improvement (PIQAT / ICQ) 

INTRODUCTION:

In Spain, the offer of prevention programmes is very varied and structured, but today the challenge remains how to put evidence into practice. European Commission define a best practice as “a relevant policy or intervention...

INTRODUCTION:

Prevention science and quality standards of drug prevention in the EU and in the world have developed in recent decades. Progress has been made in quality development in Croatia, but the experience of the process of...

BACKGROUND:

Implementing quality measurement is still a challenge in the field of drug treatment and harm reduction. In this case study, we investigate which strategies can be used to enhance the implementation of a policy in which...

INTRODUCTION:

In the favourable political climate of the mid-2010s, the standards for Assessment & Selection of Prevention programmes Issued from the Review of EDPQS (ASPIRE) were developed to support project planning in drug prevention...

BACKGROUND:

Coolmine’s implementation of quality standards involves a period of change management, strategic planning, and national policy development.

METHODS:

A narrative case study focusing on national policy and internal...

INTRODUCTION:

The Cyprus National Addictions Authority (NAAC) is the main coordinating body for all matters related to licit and illicit substances as well as pathological gambling in Cyprus and it is responsible, inter alia, for the...

BACKGROUND:

The implementation of quality standards in the treatment of substance use disorders in Lithuania is not well documented in the literature.

AIMS:

To describe the process of the development of quality standards from...

BACKGROUND:

In the field of harm reduction (HR), an established quality assurance system with implemented quality standards is rather rare in practice. Together with limited evidence in this area, this leads to an imbalance in the basic...

INTRODUCTION:

Quality Standards (QS) are an important priority in European drug policy, although the extent of their application remains unclear. The FENIQS-EU project (Further ENhancing the Implementation of Quality Standards in drug...

Background: Over the past decade, drug-related overdoses have seen a significant rise both in North America and globally. The COVID-19 pandemic has further emphasised the urgent need for safer supply programs to replace unregulated...

Abstract

Background

The prevalence and associated overdose death rates from opioid use disorder (OUD) have dramatically increased in the last decade. Despite more available treatments than 20 years ago, treatment access and high...

Abstract

Objective Tobacco use, particularly the initiation of smoking during adolescence and young adulthood, represents a significant public health concern in South Africa. This study aims to conduct a comprehensive review of published...

The Vienna & New York NGO Committees on Drugs are pleased to present the global civil society report for the 2024 mid-term review of the Commission on Narcotic Drugs (CND).
The report is the result of constructive inputs by more than 200...

INTRODUCTION:

Male infertility affects nearly 14% of men in Europe, and approximately 44% of them are unaware of the cause of their infertility. Thanks to the plentitude of research, we can now clearly define the risk factors that...

BACKGROUND:

Substance use increases the risk of damage to executive and cognitive functions. Manifested by a range of clinical symptoms, such impairments may affect people’s coping with everyday activities and their abilities to...